Literature DB >> 24797884

Adherence to dual antiplatelet therapy after coronary stenting: a systematic review.

Matthew J Czarny1, Ashwin S Nathan, Robert W Yeh, Laura Mauri.   

Abstract

BACKGROUND: Adherence to dual antiplatelet therapy (DAPT) is critical after coronary stenting. Although adherence rates are frequently assessed in clinical trials, adherence rates in the unselected population recommended for treatment but beyond clinical trials are largely unknown. Therefore, we performed a systematic review of published observational studies to describe rates of DAPT adherence, trends in DAPT use over time, and patient-level factors associated with nonadherence. HYPOTHESIS: DAPT adherence declines with increasing time after drug-eluting stent implantation.
METHODS: PubMed, Cumulative Index to Nursing and Allied Health Literature, Embase, and Web of Knowledge were searched through November 20, 2012 for studies including patients receiving 1 or more drug-eluting stents and reporting the use of aspirin and/or thienopyridines, or assessing factors associated with nonadherence to DAPT after bare metal or drug-eluting stent placement.
RESULTS: We included 34 studies in the description of DAPT adherence and 11 studies in the description of factors associated with nonadherence. Adherence to DAPT and thienopyridines was high at 1 month but declined by 12 months. Aspirin adherence was at least 90% throughout. Factors associated with nonadherence included bleeding, lower education level, immigrant status, and lack of education regarding DAPT.
CONCLUSIONS: DAPT adherence is suboptimal at 12 months, and interventions to increase adherence should focus on reducing bleeding risk and improving communication between patients and physicians.
© 2014 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24797884      PMCID: PMC4140973          DOI: 10.1002/clc.22289

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  47 in total

1.  Very late stent thrombosis and late target lesion revascularization after sirolimus-eluting stent implantation: five-year outcome of the j-Cypher Registry.

Authors:  Takeshi Kimura; Takeshi Morimoto; Yoshihisa Nakagawa; Kazuya Kawai; Shunichi Miyazaki; Toshiya Muramatsu; Nobuo Shiode; Masanobu Namura; Takahito Sone; Shigeru Oshima; Hideo Nishikawa; Yoshikazu Hiasa; Yasuhiko Hayashi; Masakiyo Nobuyoshi; Kazuaki Mitudo
Journal:  Circulation       Date:  2011-12-27       Impact factor: 29.690

2.  Identifying patients at risk for premature discontinuation of thienopyridine after coronary stent implantation.

Authors:  Alexandre S Quadros; Dulce I Welter; Fernanda O Camozzatto; Aurea Chaves; Rajendra H Mehta; Carlos A Gottschall; Renato D Lopes
Journal:  Am J Cardiol       Date:  2010-12-22       Impact factor: 2.778

3.  Frequency of and risk factors for stent thrombosis after drug-eluting stent implantation during long-term follow-up.

Authors:  Duk-Woo Park; Seong-Wook Park; Kyoung-Ha Park; Bong-Ki Lee; Young-Hak Kim; Cheol Whan Lee; Myeong-Ki Hong; Jae-Joong Kim; Seung-Jung Park
Journal:  Am J Cardiol       Date:  2006-06-12       Impact factor: 2.778

4.  Patterns of use of thienopyridine therapy after percutaneous coronary interventions with drug-eluting stents and bare-metal stents.

Authors:  Dennis T Ko; Maria Chiu; Helen Guo; Peter C Austin; Jean-François Marquis; Jack V Tu
Journal:  Am Heart J       Date:  2009-08-22       Impact factor: 4.749

5.  Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study.

Authors:  Roxana Mehran; Usman Baber; Philippe Gabriel Steg; Cono Ariti; Giora Weisz; Bernhard Witzenbichler; Timothy D Henry; Annapoorna S Kini; Thomas Stuckey; David J Cohen; Peter B Berger; Ioannis Iakovou; George Dangas; Ron Waksman; David Antoniucci; Samantha Sartori; Mitchell W Krucoff; James B Hermiller; Fayaz Shawl; C Michael Gibson; Alaide Chieffo; Maria Alu; David J Moliterno; Antonio Colombo; Stuart Pocock
Journal:  Lancet       Date:  2013-09-01       Impact factor: 79.321

6.  Clinical outcomes and stent thrombosis following off-label use of drug-eluting stents.

Authors:  Htut K Win; Angel E Caldera; Kelly Maresh; John Lopez; Charanjit S Rihal; Manish A Parikh; Juan F Granada; Sachin Marulkar; Deborah Nassif; David J Cohen; Neal S Kleiman
Journal:  JAMA       Date:  2007-05-09       Impact factor: 56.272

7.  A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators.

Authors:  M B Leon; D S Baim; J J Popma; P C Gordon; D E Cutlip; K K Ho; A Giambartolomei; D J Diver; D M Lasorda; D O Williams; S J Pocock; R E Kuntz
Journal:  N Engl J Med       Date:  1998-12-03       Impact factor: 91.245

8.  Two-year results of paclitaxel-eluting stents in patients with medically treated diabetes mellitus from the TAXUS ARRIVE program.

Authors:  John M Lasala; David A Cox; D Lynn Morris; Jeffrey A Breall; Paul D Mahoney; Phillip A Horwitz; Dinesh Shaw; Kristin L Hood; Lazar Mandinov; Keith D Dawkins
Journal:  Am J Cardiol       Date:  2009-04-16       Impact factor: 2.778

9.  Stent thrombosis after sirolimus- and paclitaxel-eluting stent implantation in daily clinical practice: analysis of a single center registry.

Authors:  Daniela Trabattoni; Franco Fabbiocchi; Piero Montorsi; Paolo Ravagnani; Stefano Galli; Giovanni Teruzzi; Giuseppe Calligaris; Stefano De Martini; Antonio L Bartorelli
Journal:  Catheter Cardiovasc Interv       Date:  2007-09       Impact factor: 2.692

10.  Assessment of sirolimus-eluting coronary stent implantation with aspirin plus low dose ticlopidine administration: one year results from CYPHER Stent Japan Post-Marketing Surveillance Registry (J-PMS).

Authors:  Yuji Ikari; Junichi Kotani; Ken Kozuma; Eishou Kyo; Masato Nakamura; Hiroyoshi Yokoi
Journal:  Circ J       Date:  2009-04-14       Impact factor: 2.993

View more
  20 in total

1.  Trends in Platelet Adenosine Diphosphate P2Y12 Receptor Inhibitor Use and Adherence Among Antiplatelet-Naive Patients After Percutaneous Coronary Intervention, 2008-2016.

Authors:  Elias J Dayoub; Matthew Seigerman; Sony Tuteja; Taisei Kobayashi; Daniel M Kolansky; Jay Giri; Peter W Groeneveld
Journal:  JAMA Intern Med       Date:  2018-07-01       Impact factor: 21.873

Review 2.  Adjudin--A Male Contraceptive with Other Biological Activities.

Authors:  Yan-Ho Cheng; Weiliang Xia; Elissa W P Wong; Qian R Xie; Jiaxiang Shao; Tengyuan Liu; Yizhou Quan; Tingting Zhang; Xiao Yang; Keyi Geng; Bruno Silvestrini; Chuen-Yan Cheng
Journal:  Recent Pat Endocr Metab Immune Drug Discov       Date:  2015

3.  Marital status and outcomes after myocardial infarction: Observations from the Canadian Observational Antiplatelet Study (COAPT).

Authors:  Olivia R Ghosh-Swaby; Mary Tan; Akshay Bagai; Andrew T Yan; Shaun G Goodman; Shamir R Mehta; Harold N Fisher; Eric A Cohen; Thao Huynh; Warren J Cantor; Michel R Le May; Jean-Pierre Déry; Robert C Welsh; Jacob A Udell
Journal:  Clin Cardiol       Date:  2018-03-25       Impact factor: 2.882

4.  Association of Ticagrelor vs Clopidogrel With Major Adverse Coronary Events in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.

Authors:  Ricky D Turgeon; Sheri L Koshman; Erik Youngson; Bryan Har; Stephen B Wilton; Matthew T James; Michelle M Graham
Journal:  JAMA Intern Med       Date:  2020-03-01       Impact factor: 21.873

5.  Consensus Document ANMCO/ANCE/ARCA/GICR-IACPR/GISE/SICOA: Long-term Antiplatelet Therapy in Patients with Coronary Artery Disease.

Authors:  Michele Massimo Gulizia; Furio Colivicchi; Maurizio Giuseppe Abrignani; Marco Ambrosetti; Nadia Aspromonte; Gabriella Barile; Roberto Caporale; Giancarlo Casolo; Emilia Chiuini; Andrea Di Lenarda; Pompilio Faggiano; Domenico Gabrielli; Giovanna Geraci; Alessio Gaetano La Manna; Aldo Pietro Maggioni; Alfredo Marchese; Ferdinando Maria Massari; Gian Francesco Mureddu; Giuseppe Musumeci; Federico Nardi; Antonio Vittorio Panno; Roberto Franco Enrico Pedretti; Massimo Piredda; Enrico Pusineri; Carmine Riccio; Roberta Rossini; Fortunato Scotto di Uccio; Stefano Urbinati; Ferdinando Varbella; Giovanni Battista Zito; Leonardo De Luca
Journal:  Eur Heart J Suppl       Date:  2018-05-31       Impact factor: 1.803

6.  Standardized classification and framework for reporting, interpreting, and analysing medication non-adherence in cardiovascular clinical trials: a consensus report from the Non-adherence Academic Research Consortium (NARC).

Authors:  Marco Valgimigli; Hector M Garcia-Garcia; Bernard Vrijens; Pascal Vranckx; Eugène P McFadden; Francesco Costa; Karen Pieper; David M Vock; Min Zhang; Gerrit-Anne Van Es; Pierluigi Tricoci; Usman Baber; Gabriel Steg; Gilles Montalescot; Dominick J Angiolillo; Patrick W Serruys; Andrew Farb; Stephan Windecker; Adnan Kastrati; Antonio Colombo; Fausto Feres; Peter Jüni; Gregg W Stone; Deepak L Bhatt; Roxana Mehran; Jan G P Tijssen
Journal:  Eur Heart J       Date:  2019-07-01       Impact factor: 29.983

7.  Real world insights on the initiation and treatment duration of oral antiplatelets in acute coronary syndromes: a retrospective cohort study.

Authors:  Marc J Claeys; Christophe Beauloye; Suzanne Pourbaix; Peter R Sinnaeve
Journal:  Eur Heart J Cardiovasc Pharmacother       Date:  2017-10-01

8.  Socioeconomic differences in experiences with treatment of coronary heart disease: a qualitative study from the perspective of elderly patients.

Authors:  Sara Lena Schröder; Astrid Fink; Matthias Richter
Journal:  BMJ Open       Date:  2018-11-13       Impact factor: 2.692

9.  Adherence to Antiplatelet Therapy after Coronary Intervention among Patients with Myocardial Infarction Attending Vietnam National Heart Institute.

Authors:  Ngoc Minh Luu; Anh Tuan Dinh; Thi Thu Ha Nguyen; Van Huy Nguyen
Journal:  Biomed Res Int       Date:  2019-04-24       Impact factor: 3.411

10.  Duration of Heightened Ischemic Stroke Risk After Acute Myocardial Infarction.

Authors:  Alexander E Merkler; Ivan Diaz; Xian Wu; Santosh B Murthy; Gino Gialdini; Babak B Navi; Shadi Yaghi; Jonathan W Weinsaft; Peter M Okin; Monika M Safford; Costantino Iadecola; Hooman Kamel
Journal:  J Am Heart Assoc       Date:  2018-11-20       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.